Category: Biotechnology
Global Biotechnology
-
Human Embryonic Stem Cell (hESC) Research
... the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected ... Read More
-
D-Amino Acids
... at a CAGR of 5.6% over the analysis period 2023-2030. Pharmaceutical End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$217.6 Million by the end of ... Read More
-
Biosimulation Technology
... at a CAGR of 15.7% over the analysis period 2023-2030. Biosimulation Software, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$5.7 Billion by the end of ... Read More
-
Biotechnology Instrumentation
... at a CAGR of 5.5% over the analysis period 2023-2030. Immunoassay Systems, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$26.1 Billion by the end of ... Read More
-
Nanotechnology in Drug Delivery
... reach US$122.7 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$35.6 ... Read More
-
G-Protein Coupled Receptors (GPCRs)
... reach US$5.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Cell Lines, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach ... Read More
-
Coatings for Medical Devices
... reach US$21.7 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Anti-Microbial Coatings, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type (Peripheral, Lymphoblastic), By Therapy (Radiotherapy, Immunotherapy, Stem Cell Transplantation), By Region, And Segment Forecasts, 2024 - 2030
... global T-cell lymphoma market size is anticipated to reach USD 3.70 billion by 2030, expanding at a CAGR of 8.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. The ... Read More
-
Global Non-Invasive Prenatal Testing Market Report by Application (Edwards Syndrome (trisomy 18), Down Syndrome (trisomy 21), Patau Syndrome (trisomy 13), Turner Syndrome, Other Applications) Component (Kits and Reagents, Instruments, Services) End User (Hospitals, Diagnostic Labs) Countries and Company Analysis, 2024-2032
... Countries and Company Analysis, 2024-2032 Global Non-Invasive Prenatal Testing Market Analysis Global Non-Invasive Prenatal Testing Market will reach US$ 9.98 billion by 2032, up from US$ 3.19 billion in 2023. This growth is indicating a ... Read More
-
Global Amniotic Membrane Market Report by Application (Ophthalmology, Surgical Wounds, Others) Product (Lyophilization Amniotic Membrane, Cryopreserved Amniotic Membrane) End User (Speciality Clinics, Hospital, Ambulatory Surgical Centers, Research & Academic Institutes) Countries and Company Analysis, 2024-2032
... Amniotic Membrane Market Analysis The Global Amniotic Membrane Market size will surpass US$ 6,588.2 Million by 2032 from US$ 2,437.7 Million in 2023, with a CAGR of 11.68% from 2024 to 2032. Some of the ... Read More
-
microRNA (miRNA)
... at a CAGR of 15.0% over the analysis period 2023-2030. microRNA Products, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$453.7 Million by the end of ... Read More
-
Amino Acids
... at a CAGR of 6.1% over the analysis period 2023-2030. Glutamic Acid, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$13.6 Billion by the end of ... Read More
-
Chromatography Accessories and Consumables
... reach US$17.7 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Solvents, Buffers & Adsorbents, one of the segments analyzed in the report, is expected to record a 5.9% CAGR ... Read More
-
2024 Global Analytical And Scientific Instruments, Excluding Optical Products Markets (2030 Outlook)
... countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 ... Read More
-
Cell Surface Markers
... by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Antibodies, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$981.1 Million by the ... Read More
-
Nanotechnology
... of 11.0% over the analysis period 2023-2030. Nanocomposites, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$71.8 Billion by the end of the analysis period. Growth ... Read More
-
Agricultural Biotechnology
... at a CAGR of 9.3% over the analysis period 2023-2030. Molecular Diagnostics, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$39.0 Billion by the end of ... Read More
-
Gene Therapy
... at a CAGR of 23.1% over the analysis period 2023-2030. Viral Gene Therapy, one of the segments analyzed in the report, is expected to record a 23.3% CAGR and reach US$5.5 Billion by the end ... Read More
-
Nanobiotechnology
... of 7.0% over the analysis period 2023-2030. Pharmaceuticals & Biotechnology End-Use Industry, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of ... Read More
-
DNA Sequencing
... at a CAGR of 11.8% over the analysis period 2023-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end ... Read More
-
Pipettes and Pipettors
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Pipette Tips, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by ... Read More
-
Drug Discovery Technologies
... by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Small Molecule Drugs Discovery Technologies, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More
-
Cardiac Biomarkers
... at a CAGR of 7.4% over the analysis period 2023-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$11.2 Billion by the ... Read More
-
Specialty Enzymes
... at a CAGR of 4.1% over the analysis period 2023-2030. Protease, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$2.1 Billion by the end of the ... Read More
-
Chiral Technology
... at a CAGR of 3.8% over the analysis period 2023-2030. Intermediates, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$8.2 Billion by the end of the ... Read More